Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma–carcinoma sequence

@article{Lee2011PromoterMS,
  title={Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma–carcinoma sequence},
  author={Kyung‐Hwa Lee and Ji-Shin Lee and J. Nam and C. Choi and Min-Cheol Lee and Chang‐Soo Park and S. Juhng and Jaehyuk Lee},
  journal={Langenbeck's Archives of Surgery},
  year={2011},
  volume={396},
  pages={1017-1026}
}
PurposeEpigenetic silencing of the DNA mismatch repair genes has been poorly described in colorectal carcinomas showing the classic adenoma–carcinoma pathway of carcinogenesis. The aim of this study was to investigate the methylation status of MutL homolog 1 (hMLH1), MutS homolog 2 (hMSH2), and O-6-methylguanine-DNA methyltransferase (MGMT) in a series of colorectal carcinomas that contain both adenomas and carcinomas.MethodsPromoter methylation of hMLH1, hMSH2, and MGMT was evaluated in normal… Expand
Expression and promoter methylation status of hMLH1, MGMT, APC, and CDH1 genes in patients with colon adenocarcinoma
TLDR
The findings suggest that DNA methylation is a useful marker for tumor progression monitoring and that promoter methylation in certain genes is associated with more advanced tumor stage, poor differentiation, and metastasis. Expand
Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens
TLDR
The hypothesis that DNA methylation in CRC depends from both physiological and environmental factors, with one-carbon metabolism largely involved in this process is supported. Expand
Relationship Between Human mutL Homolog 1 (hMLH1) Hypermethylation and Colorectal Cancer: A Meta-Analysis
TLDR
A meta-analysis of 45 articles identified a significant association between hMLH1 hypermethylation and colorectal cancer risk using the fixed-effects model and random effects model pooled. Expand
Correlation of MLH1 and MGMT methylation levels between peripheral blood leukocytes and colorectal tissue DNA samples in colorectal cancer patients
TLDR
The methylation levels of MGMT and MLH1 were moderately and weakly correlated between the patient-matched leukocytes and the normal colorectal tissue, respectively. Expand
Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer
TLDR
CDO1 methylation accumulates during the ACS process, and consistently contributes to CRC progression, according to the results of this study. Expand
Absence of hMLH1 or hMSH2 Expression as a Stage-Dependent Prognostic Factor in Sporadic Colorectal Cancers
TLDR
At initial diagnosis, metastases were found at lower rates in MMR-defective tumors, suggesting MMR status may be a stage-dependent prognostic factor in patients with sporadic colorectal cancer. Expand
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
TLDR
The hypothesis that MGMT expression may be an OS biomarker as useful as tumor stage or differentiation grade and that CD133expression may be a predictive biomarker of DFS is supported. Expand
Aberrant DNA methylation and epigenetic inactivation of hMSH2 decrease overall survival of acute lymphoblastic leukemia patients via modulating cell cycle and apoptosis.
TLDR
This study suggests that aberrant DNA methylation and epigenetic inactivation of hMSH2 play an important role in the development of ALL through altering cell growth and survival. Expand
Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis
TLDR
The results of this meta-analysis suggest that MGMT hypermethylation is associated with an increased risk and high levels of MSI and may play an important role in CRC initiation, as well as having limited value in prediction of prognosis in CRC patients. Expand
Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other Tumors.
TLDR
The impact of the context of genetic and epigenetic alterations and tumor type on the classification is investigated and technical aspects, such as robustness of cutoff definition and preprocessing of the data are reported on. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 44 REFERENCES
Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.
TLDR
Methylation analysis of hMLH1, CDKN2A/p16, and MGMT revealed specific methylation profiles for tubular adenomas, tubulovillous/villous adenoma, and colorectal cancers, supporting the use of these alterations in assessment of coloreCTal tumorigenesis. Expand
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.
  • J. Herman, A. Umar, +12 authors S. Baylin
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 1998
TLDR
The results suggest that microsatellite instability in sporadic colorectal cancer often results from epigenetic inactivation of hMLH1 in association with DNA methylation. Expand
Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon.
TLDR
Loss of hMLH1 and MGMT play a prominent role in the serrated pathway of carcinogenesis in the colon as well as MIB-1, p53, and beta-catenin immunoexpression in an uncommon cohort of mixed colonic polyps. Expand
MGMT promoter methylation and field defect in sporadic colorectal cancer.
TLDR
Some colorectal cancers arise from a field defect defined by epigenetic inactivation of MGMT, and detection of this abnormality may ultimately be useful in risk assessment for coloreCTal cancer. Expand
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.
TLDR
The presence of aberrant hypermethylation was associated with loss of MGMT protein, in contrast to retention of protein in the majority of tumors without aberrantHypermethylation, suggesting that epigenetic inactivation of MG MT plays an important role in primary human neoplasia. Expand
Promoter hypermethylation of tumor‐related genes in the progression of colorectal neoplasia
TLDR
The study demonstrated the early and specific involvement of promoter hypermethylation in the colorectal adenoma‐carcinoma sequence and there was no significant association between promoter hyperethylation and other clinicopathologic characteristics of cancer. Expand
Mapping of the methylation pattern of the hMSH2 promoter in colon cancer, using bisulfite genomic sequencing
TLDR
This study mapped the complete methylation status of the hMSH2 promoter, a region that contains 75 CpG sites, using bisulfite genomic sequencing in 60 primary colorectal cancers and demonstrated that h MSH2 hypermethylation and protein expression were associated with the development of coloreCTal cancer. Expand
Promoter methylation of P16, RARβ, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing
TLDR
This data demonstrated p16 promoter methylation in a highly tumour specific pattern and Cytoglobin is a novel candidate tumour suppressor gene highly methylated in upper aero-digestive tract squamous cancer. Expand
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
TLDR
Methylated ADAMTS1, MGMT, and MAL are suitable as markers for early tumor detection, and MSI and mutated BRAF were associated with samples harboring hypermethylation of several target genes. Expand
CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer
TLDR
The aberrant methylation of genes appears to increase most significantly during the progression of early adenomas to advancedAdenomas, and the frequency of specific gene methylation at the different steps of the adenoma‐carcinoma progression sequence varies in a gene‐specific fashion. Expand
...
1
2
3
4
5
...